HCV Medication Receipt Among Individuals With Methamphetamine, Opioid, and Alcohol Use Disorders in Arkansas, 2018–2022: A Long Road Ahead for HCV Elimination in the US South
Background. Methamphetamine and opioid use disorders (MUD/OUD) are increasing in the US, paralleled by a surge in hepatitis C virus (HCV). HCV is curable with direct-acting antiviral medication (DAA), but people with HCV who use drugs often don’t receive it. We estimated differences in DAA by substa...
Main Author: | |
---|---|
Contributors: | ; ; ; ; |
Format: | Electronic Article |
Language: | English |
Published: |
2025
|
In: |
Journal of drug issues
Year: 2025, Volume: 55, Issue: 3, Pages: 434-449 |
Online Access: |
Volltext (lizenzpflichtig) |
Journals Online & Print: | |
Check availability: | HBZ Gateway |
Keywords: |